Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Total Debt: 2010-2024

Historic Total Debt for UNITED THERAPEUTICS (UTHR) over the last 12 years, with Dec 2024 value amounting to $300.0 million.

  • UNITED THERAPEUTICS's Total Debt fell 66.67% to $200.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $1.4 billion, marking a year-over-year decrease of 51.72%. This contributed to the annual value of $300.0 million for FY2024, which is 57.14% down from last year.
  • According to the latest figures from FY2024, UNITED THERAPEUTICS's Total Debt is $300.0 million, which was down 57.14% from $700.0 million recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Total Debt registered a high of $800.0 million during FY2020, and its lowest value of $300.0 million during FY2024.
  • Moreover, its 3-year median value for Total Debt was $700.0 million (2023), whereas its average is $600.0 million.
  • Data for UNITED THERAPEUTICS's Total Debt shows a maximum YoY crashed of 57.14% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows UNITED THERAPEUTICS's Total Debt stood at $800.0 million in 2020, then remained steady at $800.0 million in 2021, then remained steady at $800.0 million in 2022, then fell by 12.50% to $700.0 million in 2023, then tumbled by 57.14% to $300.0 million in 2024.